Sakura Finetek USA launches 2 new antibodies under the Genemed® b...
Sakura Finetek USA, Inc. today announced the launch of 2 new antibodies, including PRAME (PReferentially expressed Antigen in MElanoma). The anti-PRAME antibody is a useful aid in the differential diagnosis of melanoma versus benign melanocytic ...
READ MORE